฿86.09
+฿0.09(+0.10%)
data.updated
v2.stock.overview v2.daily.trading v2.range.52w
key.stats
yesterday.close฿91.24
market.size฿16.65B
volume.trade3.35M
pe.ratio25.25
div.yield1.11%
div.amount฿0.24
diluted.eps3.90
net.income฿705.20M
revenue฿8.23B
earnings.date2026-08-06
eps.estimate1.99
rev.estimate฿2.13B
shares.out182.54M
beta0.472
ex.div.date2026-06-25
div.pay.date2026-07-31
about.stock
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
sectorHealthcare
industryMedical - Devices
ceoIvan Tornos
headquartersWarsaw,IN,US
websitehttps://www.zimmerbiomet.com
employees17.00K
avg.revenue฿484.20K
income.per.emp฿41.48K
stock.faq
stock.price
x
current.stats
52w.range.q
x
pe.ratio.q
x
market.cap.q
x
eps.recent.q
x
buy.sell.q
x
price.factors
x
buy.how
x
risk.warn
risk.notice
disclaimer2
risk.disclosure






